Sherrie Jill Divito, M.D.,Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stevens-Johnson Syndrome | 5 | 2023 | 277 | 2.080 |
Why?
|
| Skin | 10 | 2022 | 4353 | 1.080 |
Why?
|
| Dapsone | 2 | 2019 | 54 | 0.820 |
Why?
|
| Dendritic Cells | 9 | 2019 | 2723 | 0.810 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2021 | 485 | 0.750 |
Why?
|
| Focal Dermal Hypoplasia | 2 | 2016 | 8 | 0.730 |
Why?
|
| Angiomatosis | 1 | 2020 | 49 | 0.720 |
Why?
|
| Skin Diseases, Vascular | 1 | 2020 | 39 | 0.700 |
Why?
|
| Plant Extracts | 2 | 2020 | 469 | 0.690 |
Why?
|
| Leprosy | 1 | 2019 | 127 | 0.670 |
Why?
|
| Immunologic Memory | 3 | 2021 | 1348 | 0.620 |
Why?
|
| Skin Diseases | 2 | 2020 | 1065 | 0.620 |
Why?
|
| Graft vs Host Disease | 2 | 2020 | 2951 | 0.600 |
Why?
|
| T-Lymphocytes | 7 | 2021 | 10163 | 0.560 |
Why?
|
| Cell Migration Assays | 1 | 2016 | 23 | 0.560 |
Why?
|
| Drug Hypersensitivity | 2 | 2022 | 883 | 0.540 |
Why?
|
| Keratitis, Herpetic | 3 | 2010 | 81 | 0.460 |
Why?
|
| Herpesvirus 1, Human | 4 | 2010 | 742 | 0.460 |
Why?
|
| Janus Kinases | 1 | 2014 | 244 | 0.450 |
Why?
|
| Antigens | 1 | 2019 | 1462 | 0.440 |
Why?
|
| Bone Diseases | 1 | 2016 | 416 | 0.440 |
Why?
|
| Immune Tolerance | 2 | 2019 | 2257 | 0.430 |
Why?
|
| Alopecia Areata | 1 | 2014 | 106 | 0.420 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2011 | 129 | 0.390 |
Why?
|
| Corneal Stroma | 2 | 2010 | 170 | 0.370 |
Why?
|
| T-Lymphocytes, Cytotoxic | 2 | 2014 | 1820 | 0.340 |
Why?
|
| Cell Cycle | 1 | 2016 | 2964 | 0.300 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2019 | 2986 | 0.290 |
Why?
|
| Acute Disease | 1 | 2017 | 7141 | 0.280 |
Why?
|
| Lymphocyte Activation | 5 | 2021 | 5519 | 0.270 |
Why?
|
| Dermatology | 1 | 2015 | 870 | 0.260 |
Why?
|
| Immune System | 3 | 2015 | 804 | 0.240 |
Why?
|
| Antigen Presentation | 4 | 2019 | 1284 | 0.240 |
Why?
|
| Virus Activation | 1 | 2006 | 319 | 0.240 |
Why?
|
| Models, Immunological | 1 | 2006 | 527 | 0.230 |
Why?
|
| CD4-Positive T-Lymphocytes | 5 | 2022 | 4379 | 0.220 |
Why?
|
| Virus Latency | 1 | 2006 | 356 | 0.220 |
Why?
|
| Biomedical Research | 2 | 2015 | 3306 | 0.220 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2017 | 4438 | 0.210 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 5425 | 0.210 |
Why?
|
| Antigen-Presenting Cells | 2 | 2020 | 969 | 0.200 |
Why?
|
| Interleukin-15 | 2 | 2017 | 184 | 0.200 |
Why?
|
| Skin Neoplasms | 3 | 2023 | 5662 | 0.200 |
Why?
|
| HLA Antigens | 2 | 2023 | 1382 | 0.190 |
Why?
|
| Cell Proliferation | 1 | 2016 | 10472 | 0.180 |
Why?
|
| Protein Kinase Inhibitors | 2 | 2023 | 5522 | 0.180 |
Why?
|
| Exosomes | 2 | 2016 | 412 | 0.170 |
Why?
|
| Eosinophilia | 1 | 2024 | 531 | 0.170 |
Why?
|
| Animals | 22 | 2021 | 168561 | 0.170 |
Why?
|
| Genes, T-Cell Receptor beta | 1 | 2018 | 71 | 0.160 |
Why?
|
| Interferon-gamma | 4 | 2020 | 3199 | 0.160 |
Why?
|
| HLA-B Antigens | 1 | 2019 | 353 | 0.150 |
Why?
|
| Mice, Inbred NOD | 2 | 2020 | 1875 | 0.150 |
Why?
|
| Disease Models, Animal | 2 | 2015 | 18006 | 0.150 |
Why?
|
| Isoantigens | 2 | 2010 | 567 | 0.140 |
Why?
|
| Mice, Inbred BALB C | 6 | 2016 | 6382 | 0.140 |
Why?
|
| Mycosis Fungoides | 1 | 2018 | 163 | 0.140 |
Why?
|
| Mice, SCID | 2 | 2020 | 2715 | 0.140 |
Why?
|
| Humans | 31 | 2024 | 742088 | 0.140 |
Why?
|
| Mice, Inbred C3H | 3 | 2016 | 964 | 0.130 |
Why?
|
| Melanoma | 2 | 2011 | 5462 | 0.130 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2017 | 402 | 0.130 |
Why?
|
| Nails | 1 | 2016 | 291 | 0.130 |
Why?
|
| Skin Diseases, Vesiculobullous | 1 | 2015 | 85 | 0.130 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1780 | 0.120 |
Why?
|
| Interleukin-17 | 1 | 2020 | 900 | 0.120 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 1239 | 0.120 |
Why?
|
| Pemphigus | 1 | 2014 | 103 | 0.120 |
Why?
|
| Mice | 15 | 2020 | 81045 | 0.120 |
Why?
|
| Hypersensitivity | 1 | 2022 | 1093 | 0.120 |
Why?
|
| Graft Rejection | 4 | 2016 | 4393 | 0.120 |
Why?
|
| Research | 1 | 2022 | 1999 | 0.110 |
Why?
|
| Hair | 1 | 2016 | 483 | 0.110 |
Why?
|
| Frameshift Mutation | 1 | 2015 | 399 | 0.110 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2021 | 1837 | 0.110 |
Why?
|
| Chlorhexidine | 1 | 2014 | 162 | 0.110 |
Why?
|
| Sirolimus | 1 | 2020 | 1562 | 0.110 |
Why?
|
| Mosaicism | 1 | 2015 | 440 | 0.110 |
Why?
|
| Mice, Transgenic | 3 | 2015 | 9735 | 0.100 |
Why?
|
| Receptors, Tachykinin | 1 | 2011 | 25 | 0.100 |
Why?
|
| Anti-Infective Agents, Local | 1 | 2014 | 250 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 1411 | 0.100 |
Why?
|
| Nociceptors | 1 | 2015 | 432 | 0.100 |
Why?
|
| Cytokines | 4 | 2017 | 7317 | 0.100 |
Why?
|
| Tachykinins | 1 | 2011 | 78 | 0.100 |
Why?
|
| Catheter-Related Infections | 1 | 2014 | 252 | 0.100 |
Why?
|
| Psoriasis | 2 | 2017 | 898 | 0.100 |
Why?
|
| Interleukin-12 Subunit p35 | 1 | 2010 | 20 | 0.090 |
Why?
|
| Transplantation | 1 | 2012 | 217 | 0.090 |
Why?
|
| Interleukin-12 Subunit p40 | 1 | 2010 | 55 | 0.090 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2020 | 2038 | 0.090 |
Why?
|
| Endosomes | 1 | 2011 | 520 | 0.080 |
Why?
|
| Antimalarials | 1 | 2015 | 903 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2020 | 3502 | 0.080 |
Why?
|
| Transplantation, Homologous | 3 | 2016 | 4771 | 0.080 |
Why?
|
| Patient Care Team | 1 | 2020 | 2527 | 0.080 |
Why?
|
| Autoimmune Diseases | 2 | 2019 | 2130 | 0.080 |
Why?
|
| Infant | 2 | 2023 | 35070 | 0.080 |
Why?
|
| Chemokine CCL4 | 1 | 2008 | 128 | 0.080 |
Why?
|
| Lipid Metabolism | 1 | 2017 | 1887 | 0.080 |
Why?
|
| Cell Division | 1 | 2016 | 4564 | 0.080 |
Why?
|
| Cytoplasmic Vesicles | 1 | 2008 | 74 | 0.080 |
Why?
|
| Galectin 1 | 1 | 2009 | 131 | 0.080 |
Why?
|
| Nervous System | 1 | 2011 | 553 | 0.080 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 1420 | 0.080 |
Why?
|
| Child, Preschool | 2 | 2023 | 40955 | 0.080 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2023 | 4029 | 0.080 |
Why?
|
| Organ Transplantation | 2 | 2015 | 1135 | 0.070 |
Why?
|
| Cell Transplantation | 1 | 2009 | 477 | 0.070 |
Why?
|
| Genetic Testing | 1 | 2020 | 3439 | 0.070 |
Why?
|
| Neurons | 1 | 2006 | 9325 | 0.070 |
Why?
|
| Flow Cytometry | 4 | 2012 | 5975 | 0.070 |
Why?
|
| DNA Primers | 1 | 2010 | 2892 | 0.070 |
Why?
|
| Dogs | 1 | 2010 | 3910 | 0.070 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3585 | 0.070 |
Why?
|
| Early Diagnosis | 1 | 2010 | 1184 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2011 | 942 | 0.070 |
Why?
|
| Prospective Studies | 2 | 2020 | 53187 | 0.060 |
Why?
|
| Female | 14 | 2023 | 379592 | 0.060 |
Why?
|
| Cell Communication | 1 | 2011 | 1619 | 0.060 |
Why?
|
| Mast Cells | 1 | 2011 | 1544 | 0.060 |
Why?
|
| Transplantation Tolerance | 1 | 2009 | 617 | 0.060 |
Why?
|
| Adult | 7 | 2024 | 213712 | 0.050 |
Why?
|
| Aged, 80 and over | 4 | 2023 | 57683 | 0.050 |
Why?
|
| Herpes Simplex | 1 | 2006 | 466 | 0.050 |
Why?
|
| Child | 2 | 2023 | 77478 | 0.050 |
Why?
|
| Adolescent | 2 | 2023 | 85649 | 0.050 |
Why?
|
| Male | 8 | 2023 | 349538 | 0.050 |
Why?
|
| Acetamides | 1 | 2023 | 249 | 0.050 |
Why?
|
| Spleen | 3 | 2016 | 2359 | 0.050 |
Why?
|
| Tissue Donors | 1 | 2010 | 2205 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2024 | 778 | 0.050 |
Why?
|
| Middle Aged | 6 | 2023 | 213127 | 0.050 |
Why?
|
| Mice, Knockout | 3 | 2010 | 14554 | 0.050 |
Why?
|
| Mice, Inbred C57BL | 4 | 2016 | 21821 | 0.050 |
Why?
|
| Young Adult | 3 | 2023 | 56350 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2023 | 13655 | 0.050 |
Why?
|
| Research Design | 1 | 2016 | 5979 | 0.040 |
Why?
|
| Neutrophils | 2 | 2010 | 3711 | 0.040 |
Why?
|
| Cornea | 1 | 2007 | 1497 | 0.040 |
Why?
|
| Base Sequence | 1 | 2010 | 12797 | 0.040 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2005 | 810 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7873 | 0.040 |
Why?
|
| Inflammation | 2 | 2022 | 10578 | 0.040 |
Why?
|
| Skin Transplantation | 2 | 2016 | 1074 | 0.040 |
Why?
|
| Vaccinia | 1 | 2017 | 76 | 0.040 |
Why?
|
| Hypoglycemic Agents | 1 | 2009 | 2866 | 0.040 |
Why?
|
| Fibroblasts | 1 | 2007 | 4143 | 0.040 |
Why?
|
| Heart Transplantation | 3 | 2016 | 3119 | 0.040 |
Why?
|
| HIV Infections | 1 | 2022 | 16678 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2011 | 9144 | 0.030 |
Why?
|
| Retrospective Studies | 2 | 2023 | 77098 | 0.030 |
Why?
|
| Lymphoma, T-Cell, Cutaneous | 1 | 2018 | 206 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2016 | 24913 | 0.030 |
Why?
|
| Pharmacogenetics | 1 | 2020 | 676 | 0.030 |
Why?
|
| Aged | 4 | 2023 | 162944 | 0.030 |
Why?
|
| MicroRNAs | 1 | 2011 | 3731 | 0.030 |
Why?
|
| Apoptosis | 2 | 2009 | 9715 | 0.030 |
Why?
|
| Congresses as Topic | 1 | 2020 | 764 | 0.030 |
Why?
|
| Vaccinia virus | 1 | 2017 | 349 | 0.030 |
Why?
|
| Fatty Acid-Binding Proteins | 1 | 2017 | 301 | 0.030 |
Why?
|
| Consensus | 1 | 2024 | 2935 | 0.030 |
Why?
|
| Clone Cells | 1 | 2018 | 1692 | 0.030 |
Why?
|
| Mycobacterium tuberculosis | 1 | 2005 | 1825 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2009 | 3336 | 0.030 |
Why?
|
| Transplants | 1 | 2016 | 208 | 0.030 |
Why?
|
| Acyltransferases | 1 | 2015 | 294 | 0.030 |
Why?
|
| International Cooperation | 1 | 2020 | 1421 | 0.030 |
Why?
|
| Methylprednisolone | 1 | 2014 | 388 | 0.030 |
Why?
|
| Major Histocompatibility Complex | 1 | 2016 | 935 | 0.030 |
Why?
|
| Pyrazoles | 1 | 2023 | 1970 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2022 | 2524 | 0.030 |
Why?
|
| Cell Differentiation | 1 | 2010 | 11470 | 0.030 |
Why?
|
| Mycophenolic Acid | 1 | 2014 | 343 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3862 | 0.030 |
Why?
|
| Bandages | 1 | 2014 | 267 | 0.030 |
Why?
|
| Biological Transport | 1 | 2017 | 2119 | 0.030 |
Why?
|
| Oxidation-Reduction | 1 | 2017 | 2187 | 0.020 |
Why?
|
| Immunity, Innate | 1 | 2022 | 2956 | 0.020 |
Why?
|
| Immunosuppressive Agents | 2 | 2014 | 4147 | 0.020 |
Why?
|
| Membrane Fusion | 1 | 2011 | 273 | 0.020 |
Why?
|
| Adoptive Transfer | 1 | 2012 | 844 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2014 | 1849 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2012 | 1827 | 0.020 |
Why?
|
| Cross-Priming | 1 | 2009 | 82 | 0.020 |
Why?
|
| Injections, Intraperitoneal | 1 | 2009 | 424 | 0.020 |
Why?
|
| Cytosol | 1 | 2011 | 901 | 0.020 |
Why?
|
| Models, Animal | 1 | 2015 | 2170 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2011 | 23387 | 0.020 |
Why?
|
| Lymphocyte Depletion | 1 | 2010 | 608 | 0.020 |
Why?
|
| Age of Onset | 1 | 2014 | 3266 | 0.020 |
Why?
|
| Mice, Inbred A | 1 | 2007 | 248 | 0.020 |
Why?
|
| Cell Survival | 1 | 2017 | 5872 | 0.020 |
Why?
|
| Graft Survival | 1 | 2016 | 3733 | 0.020 |
Why?
|
| Glucocorticoids | 1 | 2014 | 2107 | 0.020 |
Why?
|
| Th1 Cells | 1 | 2010 | 1056 | 0.020 |
Why?
|
| Lymphocyte Count | 1 | 2007 | 792 | 0.020 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 3691 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2018 | 12242 | 0.020 |
Why?
|
| Registries | 1 | 2020 | 8077 | 0.020 |
Why?
|
| Cell Movement | 1 | 2016 | 5212 | 0.010 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2007 | 1368 | 0.010 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3920 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2018 | 8425 | 0.010 |
Why?
|
| Insulin-Secreting Cells | 1 | 2009 | 891 | 0.010 |
Why?
|
| Critical Illness | 1 | 2014 | 2665 | 0.010 |
Why?
|
| Kidney Transplantation | 1 | 2016 | 4246 | 0.010 |
Why?
|
| Diagnosis, Differential | 1 | 2014 | 12958 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 10248 | 0.010 |
Why?
|
| Prognosis | 1 | 2018 | 29010 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 12344 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2008 | 13814 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2011 | 9410 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2008 | 18112 | 0.010 |
Why?
|
| Disease Progression | 1 | 2010 | 13256 | 0.010 |
Why?
|
| Lung | 1 | 2005 | 9826 | 0.000 |
Why?
|